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Background:  Particulate  matter  (PM)  from  trafﬁc and  other  sources  has  been  associated  with  adverse
health  effects.  One  unifying  theory  is  that  PM,  whatever  its source,  acts on  the  human  body  via  its capacity
to  cause  damaging  oxidation  reactions  related  to its  content  of pro-oxidants  components.  Few  epidemio-
logical  studies  have  investigated  particle  oxidative  potential  (OP)  and  health.  We  conducted  a time  series
analysis  to assess  associations  between  daily  particle  OP measures  and  numbers  of  deaths  and  hospital
admissions  for  cardiovascular  and  respiratory  diseases.
Methods:  During  2011  and  2012  particles  with  an  aerodynamic  diameter  less  than  2.5  and  10 m  (PM2.5
and  PM10 respectively)  were  collected  daily  on  Partisol  ﬁlters  located  at an urban  background  monitoring
station  in Central  London.  Particulate  OP was assessed  based  on  the  capacity  of the  particles  to oxidize
ascorbate  (OPAA)  and  glutathione  (OPGSH)  from  a simple  chemical  model  reﬂecting  the antioxidant  com-
position  of  human  respiratory  tract  lining  ﬂuid.  Particulate  OP,  expressed  as  % loss  of  antioxidant  per  g
of PM,  was  then  multiplied  by  the daily  concentrations  of  PM  to derive  the  daily  OP  of  PM mass  concentra-
tions  (%  loss per m3). Daily  numbers  of  deaths  and  age-  and  cause-speciﬁc  hospital  admissions  in London
were  obtained  from  national  registries.  Poisson  regression  accounting  for seasonality  and  meteorology
was  used  to estimate  the  percentage  change  in  risk  of death  or  admission  associated  with  an  interquartile
increment  in particle  OP.
Results:  We  found  little  evidence  for adverse  associations  between  OPAA and  OPGSH and  mortality.  Asso-
ciations  with  cardiovascular  admissions  were  generally  positive  in  younger  adults  and  negative  in  older
adults  with  conﬁdence  intervals  including  0%. For  respiratory  admissions  there  was  a  trend,  from  positive
to negative  associations,  with  increasing  age although  conﬁdence  intervals  generally  included  0%.
Conclusions:  Our  study,  the  ﬁrst to analyse  daily  particle  OP  measures  and  mortality  and  admissions
in  a large  population  over  two  years, found  little  evidence  to  support  the  hypothesis  that  short-term
exposure  to  particle  OP  is  associated  with  adverse  health  effects.  Further  studies  with  improved  exposure
assessment  and  longer  time  series  are  required  to conﬁrm  or  reject  the  role  of  particle  OP in triggering
exacerbations  of  disease.
© 2016  The  Authors.  Published  by  Elsevier  GmbH.  This  is  an open  access  article  under  the  CC  BY. IntroductionRecent comprehensive reviews have concluded that there is suf-
cient epidemiological, toxicological and mechanistic evidence to
ink ambient outdoor concentrations of particulate matter (PM)
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with adverse effects on human health (EPA, 2009; WHO, 2013).
Epidemiological time series studies have provided the evidence for
associations in urban populations between daily mass concentra-
tions of particles with a median diameter less than 2.5 m (PM2.5)
and increased numbers of deaths and hospital admissions from a
range of cardiovascular and respiratory diseases within a few days
(Atkinson et al., 2014). However, better understanding of the most
harmful components, and sources, of the particulate pollution is
required in order to better inform policies to protect public health.
le under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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o date, particle characteristics such as size and number, primary
s. secondary origin and elemental composition have all been inves-
igated (Atkinson et al., 2015; EPA, 2011; Janssen et al., 2011; Levy
t al., 2012; Ruckerl et al., 2011).
Exposure to PM from trafﬁc or other sources is associated with
 range of human responses including neutrophilic inﬂammation,
educed inspiratory capacity, heightened bronchial reactivity, as
ell as changes in blood viscosity, ﬁbrinogen, C-reactive protein
nd heart rate variability (HEI, 2010). One unifying theory is that
articles elicit these responses by inducing oxidative stress via a
ange of mechanisms: (a) related to their content of pro-oxidants,
uch as metals and quinones (Ayres et al., 2008); (b) via the cellular
etabolism of polyaromatic hydrocarbons (Baulig et al., 2004); (c)
hrough the induction of acute inﬂammation, with activation of the
hagocytic NADPH oxidase (Hamad et al., 2016); and (d) by depo-
arisation of the mitochondrial electron transport chain (Ferecatu
t al., 2010; Xu et al., 2011). The oxidative potential (OP) of PM may
herefore provide a useful, unifying metric for assessing the toxic-
ty of particles in epidemiological studies (Ayres et al., 2008; Kelly
nd Fussell, 2015).
Because laboratory assessment of particle OP is time and
esource intensive, the use of this metric in epidemiological time
eries studies has been limited to a small number of experimen-
al and panel studies (Delﬁno et al., 2013; Steenhof et al., 2013;
trak et al., 2012) and a single case-crossover study of COPD/asthma
ospital admissions (Canova et al., 2014). The latter found no evi-
ence of an association with particle OP, but was limited to 161
dmissions to a single London hospital. In contrast, a study of
mergency department visits for asthma/wheezing and congestive
eart failure in Atlanta found stronger associations with parti-
le OP than particle mass (PM2.5) (Bates et al., 2015). Two recent
tudies from Canada have estimated the OP of daily PM2.5 using
egional OP estimates derived from periodic sampling of PM ﬁlters
nd reported stronger associations between PM2.5 concentrations
nd emergency room visits for myocardial infarction and respira-
ory disease on days with higher particle OP (Weichenthal et al.,
016b; Weichenthal et al., 2016c). A recent cohort study found
hat adjustment for regional glutathione-related, but not ascorbate
ependent, oxidative potential was associated with an increased
isk of death and that for lung cancer the association may  be
tronger than for PM2.5 mass concentrations (Weichenthal et al.,
016a). To date, daily measures of particle OP have not been evalu-
ted in a large urban conurbation in relation to daily mortality and
dmissions from cardiorespiratory diseases. Using laboratory anal-
sis of samples obtained from daily particle measurements made at
 monitoring station in Central London, U.K. we derived measures
f ascorbate and glutathione-dependent OP for PM2.5 and particles
ith an median diameter less than 10 m (PM10) and investigated
ssociations with daily numbers of deaths and hospital admissions
or cardiovascular and respiratory diseases.
. Methods
.1. Health data
Daily counts of deaths from all non-accidental causes (ICD-10
hapters A-R), cardiovascular (ICD-10 Chapter I) and respiratory
auses (ICD-10 Chapter J) for people resident and dying in London,
ngland between January 2011 and December 2012 were con-
tructed from death registrations obtained from the UK Ofﬁce of
ational Statistics. For the same time period and using the same
CD-10 codes, daily counts of the numbers of emergency, ﬁrst
pisode, hospital admissions for cardiovascular disease and for res-
iratory diseases stratiﬁed by age (0–14, 15–64 and 65+ years) wereand Environmental Health 219 (2016) 566–572 567
derived from records of individual admissions obtained from the
English Hospital Episode Statistics system.
2.2. Particle oxidative potential measurement
The oxidative potential of particles (PM10 and PM2.5) was
determined by measuring the depletion of the anti-oxidants ascor-
bate and glutathione from a synthetic respiratory tract lining
ﬂuid (RTLF). The synthetic RTLF contains the major low-molecular
weight sacriﬁcial antioxidants commonly found on the surface of
the lung, at physiologically relevant concentrations and allows
analysis of different chemical mechanisms of oxidative damage that
PM may  inﬂict on airways. The underlying principle of this assay
and the derivation of the OP metrics have been described in detail
previously (Godri et al., 2010; Kelly et al., 2011). This method was
adapted to perform the analysis on unextracted ﬁlters to accom-
modate the low ﬁlter loadings associated with 24 h collections at
urban background locations which impact on PM recovery from the
ﬁlter, but also to avoid potential artifacts being introduced through
the extraction procedure.
PM was collected onto Teﬂon-coated glass ﬁbre ﬁlters (Pallfex
EmfabTM) using Partisol 2025 samplers (Thermo) using PM10 or
PM2.5 size selective inlets during 2011–12 from the North Kens-
ington background monitoring site (51.521055 N, 0.213432 W)
in Central London. From each ﬁlter, 3 × 8 mm discs were punched
(Harris Unicore, USA) and transferred into three separate micro-
tubes for analysis. The ﬁlter punches were then incubated for 4 h at
pH 7.0, 37 ◦C, with continual mixing throughout, in synthetic RTLF,
containing equimolar concentrations (200 mol/L) of the antiox-
idants ascorbate, urate and glutathione. Particle free controls to
quantify auto-oxidative losses of RTLF antioxidants, and in-house
positive (NIST srm 1648a) and negative (M120–an inert carbon
black (Cabot Corp., USA) (Zielinski et al., 1999)) control particles
were also included to control for batch-to-batch variation. At the
end of the incubation period samples were centrifuged for 1-h at
13,000 rpm (4 ◦C) to remove the ﬁlters and any disassociated PM
and the supernatant quantiﬁed for the remaining concentrations
of ascorbate by reverse-phase HPLC with electrochemical detec-
tion. The concentration of glutathione remaining in the RTLF at this
time point was quantiﬁed using the DTNB-enzyme recycling assay.
The derivation of the ascorbate and glutathione dependent oxida-
tive potentials was based on the percentage loss of antioxidants
relative to the particle free control concentrations at the 4-h time
point, normalized for the concentration of PM on the ﬁlter punch,
i.e. % antioxidant loss per g. Filter masses were based on pre- and
post-weighing following exposures in the ﬁeld with the masses on
the ﬁlter punches calculated based on the assumption of equal par-
ticle deposition across the ﬁlter area. Finally the ascorbate (OPAA)
and glutathione (OPGSH) depletion expressed as % loss per g of PM
were multiplied by the ambient daily PM2.5 or PM10 concentrations
to provide daily OP metrics (% loss) expressed per m3. Measure-
ments for OPAA and OPGSH in PM10 and PM2.5 were available for
703 and 685 days in the two  year study period, the difference in
numbers reﬂecting periods when the samplers were not operating
due to technical issues.
2.3. Regulated pollutants and meteorological variables
Hourly average concentrations of PM10, PM2.5, nitrogen diox-
ide (NO2), sulphur dioxide (SO2) and ozone (O3) recorded at the
urban background monitoring station at North Kensington dur-
ing the study period were obtained from the Automatic Urban
Rural Network and averaged to give 24-h mean concentrations
in g/m3 for all pollutants except O3 for which the 8 h maxi-
mum  average (WHO, 2006) was computed. The Tapered Element
Oscillating Microbalance—Filter Dynamics Measurement System
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TEOM-FDMS, Thermo) was used to measure PM10 and PM2.5. O3
as measured by UV absorption, NO2 by Chemiluminescence and
O2 by UV ﬂuorescence as deﬁned in the relevant EU Directives. Gas
nd PM10 and PM2.5 instruments were independently calibrated
nd audited twice yearly by Ricardo-AEAT plc. Mean daily tem-
erature (◦C) and relative humidity (%) were also collected for the
eriod 2011–12 from a meteorological station close to the North
ensington monitoring site.
.4. Statistical analysis
To assess the relationship between the daily number of health
vents and OP concentrations, we used a generalised additive
odel assuming a Poisson distribution with adjustment for over-
ispersion. Penalized regression splines with natural spline basis
pplied to day of study were used to capture the association
etween omitted time-varying covariates and daily mortality. The
egrees of freedom (df) for time adjustment were chosen based
pon the minimization of the absolute value of the sum of the par-
ial autocorrelation function of the residuals (lags 1–30), with a
inimum of 3 df per year (Samoli et al., 2013). Average temper-
ture on the previous day and averaged over days 1–6 prior to
he date of death were modelled using spline terms and humid-
ty modelled using the average of the same and the two previous
ays’ measurement. Finally, dummy  variables for week day and
ublic holidays were included in the model. Based upon previ-
usly reported associations with particles (Atkinson et al., 2010),
e investigated associations between total mortality and CVD out-
omes using the previous days’ OP values (lag1) and for respiratory
utcomes, values two days prior to the event (lag2). As sensitiv-
ty analysis for the lag choice, we also investigated the cumulative
ffect over weekly exposure (lags0-6) using unconstrained dis-
ributed lags (DL) models (Zanobetti et al., 2002).
able 1
escriptive statistics for mortality and hospital admissions counts, concentrations of ox
ariables in London, U.K. for 1/1/2011–31/12/2012.
Number of days Percentiles
10th 
Mortality (n/day)a
Total 722 99 
Cardiovascular 722 27 
Respiratory 722 11 
Hospital Admissions (n/day)
Cardiovascular
15–64 years 731 39 
65+  years 731 76 
Respiratory
0–14  years 731 22 
15–64  years 731 48 
65+  years 731 77 
Particle oxidative potential metric (% loss/m3)
PM10 OPAA 703 8.2 
PM10 OPGSH 703 4.0 
PM2.5 OPAA 685 4.7 
PM2.5 OPGSH 685 1.5 
Pollutants (g/m3)
PM10 729 9.0 
PM2.5 730 5.0 
NO2 706 18.1 
SO2 717 0.0 
O3 716 21.7 
Meteorology
Mean  Temperature (◦C) 722 5.0 
Relative humidity (%) 722 61.6 
A—Ascorbate depletion; GSH—Glutathione depletion.
a 01/01/2011 to 22/12/2012.and Environmental Health 219 (2016) 566–572
We  also stratiﬁed our analyses by season (cool period – October-
March; warm period – April–September). The model used in the
seasonal analysis was  similar to the annual one, except for sea-
sonality and long-term trends control, for which we used indicator
variables per month per year of the study. To explore potential con-
founding by other particle components and gaseous pollutants we
adjusted for PM mass, and in turn, NO2, O3 and SO2 using multi-
pollutant models. We  initially regressed the gaseous pollutant on
particle mass (PM10 or PM2.5) and then entered the resulting model
residuals into the model estimating the effects of the oxidative
potential on the health outcome (Mostofsky et al., 2012).
Relative risks (RR) and 95% conﬁdence intervals were expressed
as percentage changes (100*(RR-1)) associated with an inter-
quartile range (IQR) increase in particle OP% loss per m3. The R
statistical package was  used for all analyses (R Development Core
Team, 2007).
3. Results
Descriptive statistics for the health outcomes, pollutants and
meteorological variables are given in Table 1. The median daily
number of deaths in London during the study period was  117. The
median number of hospital admissions was greatest in the group
aged 65 years and over, 104 and 91 per day for cardiovascular and
respiratory diseases respectively. Ascorbate depletion was higher
per m3 than glutathione depletion in both PM10 and PM2.5. Par-
ticle OPAA were moderately correlated with PM mass and NO2
(r = 0.5–0.6) and PM OPGSH were only weakly correlated with PM
mass and NO2 (r = 0.2–0.4) (Table 2). Both OP metrics were nega-
tively correlated with O3.
We found little evidence for adverse associations between
OPAA and OPGSH metrics and all-cause and cause-speciﬁc
mortality—associations were mostly negative and all 95% conﬁ-
idative potential in PM10 and PM2.5 and regulated pollutants and meteorological
25th 50th 75th 90th
107 117 128 139
31 35 40 45
13 17 21 25
46 57 65 71
87 104 115 124
33 45 56 72
55 63 71 81
79 91 107 125
11.6 17.2 26.1 35.7
5.7 8.9 12.7 17.4
7.8 12.7 18.3 25.1
2.2 4.0 7.1 10.7
11.0 15.0 21.0 32.5
6.0 9.0 14.0 25.0
23.2 33.3 46.9 58.1
0.4 1.8 2.6 3.6
39.5 54.7 69.8 85.9
8.1 11.8 15.5 18.1
69.6 77.9 84.1 88.5
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Table  2
Pearson correlation coefﬁcients between particle OP metrics, daily pollutant concentrations and temperature.
Pollutants PM10 OPAA PM10 OPGSH PM2.5 OPAA PM2.5 OPGSH PM10 PM2.5 NO2 SO2 O3
PM10 OPGSH 0.60
PM10 OPAA 0.67 0.38
PM2.5 OPGSH 0.33 0.53 0.49
PM10 0.60 0.24 0.56 0.23
PM2.5 0.59 0.22 0.58 0.24 0.95
NO2 0.60 0.36 0.64 0.40 0.66 0.66
SO2 0.34 0.15 0.37 0.16 0.51 0.49 0.52
O3 −0.36 −0.22 −0.42 −0.14 −0.19 −0.28 −0.40 −0.17
Temp  −0.25 −0.11 −0.22 −0.12 −0.20 −0.25 −0.39 −0.13 0.52
AA—Ascorbate depletion; GSH—Glutathione depletion.
Table 3
Percent change (and 95% conﬁdence intervals) in all-cause (lag 1 day), cardiovascular (lag 1 day) and respiratory (lag 2 days) mortality associated with interquartile range
(IQR)  increases in PM10, PM2.5 and particle oxidative potential. .
Pollutant Units IQR All-Cause Cardiovascular Respiratory
PM10 g/m3 8.0 −0.48 (−1.22, 0.25) −0.87 (−2.13, 0.40) −0.81 (−2.57, 0.97)
PM10 OPAA %/m3 14.5 −0.26 (−1.36, 0.85) −0.96 (−2.87, 0.98) −2.84 (−5.46, 0.16)
PM10 OPAA + PM10 %/m3 14.5 0.24 (−1.15, 1.65) −0.25 (−2.69, 2.25) −3.37 (−6.71, 0.09)
PM10 OPGSH %/m3 7.0 0.41 (−0.44, 1.27) −0.32 (−1.83, 1.21) −0.72 (−2.80, 1.39)
PM10 OPGSH + PM10 %/m3 7.0 0.60 (−0.29, 1.49) −0.06 (−1.63, 1.53) −0.49 (−2.64, 1.71)
PM2.5 g/m3 4.1 −0.58 (−1.24, 0.08) −0.90 (−2.04, 0.25) −0.47 (−2.05, 1.14)
PM2.5 OPAA %/m3 10.5 −0.49 (−1.56, 0.58) −1.72 (−3.57, 0.15) −1.31 (−3.86, 1.31)
PM2.5 OPAA + PM2.5 %/m3 10.5 0.03 (−1.28, 1.35) −1.30 (−3.59,1.05) −1.36 (−4.50, 1.88)
PM2.5 OPGSH %/m3 4.8 −0.04 (−0.81, 0.73) −0.76 (−2.13, 0.64) 0.33 (−1.49, 2.19)
PM2.5 OPGSH + PM2.5 %/m3 4.8 0.10 (−0.69, 0.90) −0.55 (−1.96, 0.87) 0.46 (−1.41, 2.36)
OPAA − Ascorbate depletion; OPGSH − Glutathione depletion.
Table 4
Percent change (and 95% conﬁdence intervals) in cardiovascular (lag 1 day) and respiratory (lag 2 days) hospital admissions associated with interquartile range (IQR) increases
in  PM10, PM2.5 and particle oxidative potential.
Pollutant Units IQR Cardiovascular Respiratory
15–64 yrs. 65 yrs.+ 0–14 yrs. 15–64 yrs. 65 yrs.+
PM10 g/m3 8.0 0.17 (−0.86, 1.21) −0.50 (−1.27, 0.28) 0.69 (−0.85, 2.25) −0.67 (−1.69, 0.37) −1.14 (−2.10, −0.16)
PM10 OPAA %/m3 14.5 0.39 (−1.12, 1.92) −0.14 (−1.29, 1.03) 2.30 (0.13, 4.51) 0.20 (−1.33, 1.74) −2.45 (−3.85, −1.02)
PM10 OPAA + PM10 %/m3 14.5 0.76 (−1.17, 2.73) 0.45 (−1.03, 1.95) 2.62 (−0.06, 5.38) 1.23 (−0.71, 3.22) −2.52 (−4.30, −0.71)
PM10 OPGSH %/m3 7.0 0.63 (−0.54, 1.81) 0.17 (−0.73, 1.08) 3.81 (1.89, 5.78) 0.33 (−0.86, 1.53) −1.87 (−2.95, −0.78)
PM10 OPGSH + PM10 %/m3 7.0 0.71 (−0.51, 1.94) 0.33 (−0.60, 1.28) 0.99 (−0.63, 2.64) 0.35 (−0.87, 1.59) −1.69 (−2.81, −0.55)
PM2.5 g/m3 4.1 0.19 (−0.73, 1.12) −0.80 (−1.49, −0.10) 0.42 (−0.94, 1.81) −0.80 (−1.72, 0.13) −0.97 (−1.84, −0.09)
PM2.5 OPAA %/m3 10.5 0.34 (−1.18, 1.89) −1.16 (−2.29, −0.01) 1.69 (−0.48, 3.90) −0.67 (−2.17, 0.85) −1.40 (−2.79, 0.02)
PM2.5 OPAA + PM2.5 %/m3 10.5 0.50 (−1.39, 2.44) −0.65 (−2.07, 0.79) 1.88 (−0.73, 4.55) 0.14 (−1.72, 2.03) −0.96 (−2.65, 0.77)
PM OPGSH %/m3 4.8 0.07 (−1.07, 1.23) −0.05 (−0.91, 0.82) 0.31 (−1.47, 2.12) −0.16 (−1.23, 0.93) −0.47 (−1.45, 0.53)
73, 1.0
O
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PM2.5 OPGSH + PM2.5 %/m3 4.8 0.11 (−1.06, 1.29) 0.15 (−0.
PAA—Ascorbate depletion; OPGSH—Glutathione depletion.
ence intervals included 0% (Table 3). Associations with cause-
nd age-speciﬁc hospital admissions are given in Table 4. For
ardiovascular admissions, associations in younger adults (15–64
ears) were positive and associations in older adults (65+ years)
ere generally negative with conﬁdence intervals that included 0%
ther than for PM2.5 OPAA and cardiovascular admissions in 65+
ge group. For respiratory admissions, positive associations were
bserved for children aged 0–14 years with the strongest associ-
tions observed for PM10 OP measures. There was little evidence
or associations between particle OP and respiratory admissions in
dults, except for negative associations with PM10 OP metrics in
ubjects over 65 years of age.Adjustment for particle mass and gaseous pollutants did not
aterially affect the estimates nor their conﬁdence intervals for
ny of the outcomes/diseases investigated (Tables 3 and 4 and Sup-
lementary material, Table 1). When stratiﬁed by warm and cool4) −0.56 (−2.04, 0.94) −0.21 (−1.31, 0.89) −0.27 (−1.28, 0.75)
periods of the year (Supplementary material, Table 2) seasonal dif-
ferences achieved statistical signiﬁcance for PM2.5 OPAA (adjusted
for PM mass) and hospital admissions for both cardiovascular and
respiratory causes which were increased during the warm season
in subjects below the age of 65 years. Results from distributed lag
models including adjustment for particle mass concentration con-
ﬁrmed the pattern of associations found for individual lags (data
not shown).
4. Discussion
We investigated associations between daily measures of the
oxidative potential of airborne particles and daily, all-cause and
cause-speciﬁc mortality and cause-speciﬁc admissions in Lon-
don for the period 2011–2012. Associations for OPAA and OPGSH
were positive for all-cause mortality and generally negative for
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ardiovascular and respiratory mortality. Associations with car-
iovascular admissions were generally positive with conﬁdence
ntervals including 0%. For respiratory admissions there was  a
rend, from positive to negative associations, with increasing age
lthough all conﬁdence intervals included 0%. We  observed some
vidence of an association between OPAA and cardiovascular and
espiratory admissions in subjects less than 65 years during the
arm season (April–September).
Our study evaluated associations between daily measures of
scorbate and glutathione depletion in PM10 and PM2.5 and daily
ounts of health events and is an example of translational research
inking laboratory to epidemiology. One feature of this approach
s that data assembly is labour intensive and therefore costly. The
ollection and analysis of particle ﬁlters to derive daily OP mea-
ures is also time consuming and therefore our study was limited by
esources to approximately 700 consecutive daily measurements.
n time series studies, statistical power is determined by the num-
er of observations (days) and the mean numbers of events per day.
hilst our study was limited with regard to the number of days this
as compensated for to some degree by the large study population,
nd hence large mean number of events, in London. However, anal-
ses with more years of data would improve the precision of our
odel estimates and aid interpretation.
A further limitation of our study, one inherent in many time
eries studies, was the potential misclassiﬁcation of exposure
ue to the use of measurements from a single background mon-
toring station in Inner London. Zeger et al. have shown that
hat matters is how well the exposure series matches the mean
aily exposures over the city as a whole (Zeger et al., 2000).
ith OP measures we have no means of evaluating this but we
ote that in London, PM2,5 daily measurements at monitoring
tations in different geographical locations were strongly corre-
ated (Puustinen et al., 2007), and supported by our own analysis
f concentrations of PM10 and PM2.5 measured at NK and at
ackground monitoring stations across London (data not shown).
e also note that a recent paper by Yang et al. has demon-
trated that PM OP measured at a central monitoring site in the
etherlands was correlated with personal exposures (Yang et al.,
015).
Oxidative stress has been proposed as a unifying mechanism
o explain the toxic effects of particulate matter (Kelly, 2003).
n a recent review, Weichenthal et al. examined existing epi-
emiological evidence related to oxidative stress defence and the
ealth effects of ﬁne particles (PM2.5) (Weichenthal et al., 2013).
heir aim was to assess the evidence for, or against, incorporating
easures of PM2.5 oxidative burden in ambient air quality man-
gement. Their review focused on studies that explored the impact
f polymorphisms in anti-oxidant related genes or anti-oxidant
upplementation and concluded that “the existing evidence gen-
rally suggested that oxidant defence may  modify the impact of
M2.5 exposure on various health outcomes, particularly heart rate
ariability”.
A small number of studies have examined the association
etween PM oxidative burden and cardiorespiratory morbidity.
onne et al. assessed the association between PM10 oxidative bur-
en and carotid intima-media thickness in a cohort of 2348 British
ivil servants (Tonne et al., 2012). The PM oxidative burden at
ubjects’ residential addresses was estimated using a geostatis-
ical spatio-temporal model applied to weekly OP measures. PM
eighted by particle OP estimates was not more predictive of the
xtent of atherosclerosis than PM mass concentration. Measured
M10 OP, together with a range of other PM metrics, were used in
n experimental study in which volunteers were exposed to PM
t ﬁve different locations including an underground train station,
wo trafﬁc sites, a farm, and an urban background site (Strak et al.,
012). Whilst changes in PNC, NO2, and NOX were associated withand Environmental Health 219 (2016) 566–572
evidence of acute airway inﬂammation and impaired lung func-
tion, PM mass concentration and PM10 oxidative potential were
not predictive of the observed acute responses. This study also
investigated relationships with thrombin formation and reported
ex vivo thrombin generation was  associated with exposure to NO2,
nitrate and sulphate, but not PM mass, PM OP or other measured
air pollutants (Strak et al., 2013). A panel of 45 schoolchildren with
persistent asthma was followed over 10 days with repeated mea-
surement of fractional exhaled nitric oxide (FENO), a biomarker
of airway inﬂammation (Delﬁno et al., 2013). Ambient exposures
included daily average PM2.5, PM2.5 elemental and organic carbon
(EC, OC), NO2, O3, and endotoxin. PM2.5 oxidative potential was
assessed using both an abiotic and an in vitro bioassay on aqueous
extracts of daily particle ﬁlters. FENO was associated with both OP
metrics as well as trafﬁc markers (EC, OC, and NO2) but not PM2.5
mass. In a bi-directional case-crossover study in patients admit-
ted to the hospital for asthma/COPD exacerbation compared PM10
oxidative potential on the day of admission with that on 14 days
before/after (Canova et al., 2014). OP measured by AA and GSH
depletion showed no association with asthma/COPD admissions,
with and without adjustment for PM10 mass.
Our study is the ﬁrst to assess associations between daily mea-
sures of the oxidative potential of PM10 and PM2.5 in a time series
design including mortality and hospital admissions for cardiorespi-
ratory diseases stratiﬁed by age groups. Our results are consistent
with the generally null ﬁndings reported in the (small) literature
base. There are a number of possible explanations for this lack of
epidemiological evidence. First, the mechanism(s) by which parti-
cles affect human health over short durations are not driven by
oxidation reactions or oxidative stress induced by particles. We
note, however, that we also found no evidence for associations
between PM mass and daily mortality and hospital admissions in
adults over 65+ years during the same period (Atkinson et al., 2016;
Samoli et al., 2016). Secondly, the exposure metrics used (measure-
ments made at a single background site) do not represent well the
exposure of the population at risk or that the day-to-day variation in
OP exposure is insufﬁcient to enable detection of associations with
health. Finally, the particular assay used did not adequately reﬂect
the true biological oxidative potential of the particles monitored
(Weichenthal et al., 2013). Previous studies have demonstrated that
fresh tail pipe PM has low intrinsic OP in chemical models (Barath
et al., 2010), but have the capacity to elicit intra-cellular ROS via
PAH activation through xenobiotic metabolism (Baulig et al., 2004).
Therefore, it may  be the case that the chemical models are simply
not conﬁgured to be informative about this aspect of the parti-
cles downstream toxicity. As an aside a number of other assays
are available to assess the intrinsic OP of PM, based on the oxi-
dation of dithiothreitol (DTT), the oxidation of ﬂuorescent probes,
or the spin trapping of radicals and their quantiﬁcation by elec-
tron paramagnetic resonance (Ayres et al., 2008). While there is
no standardised assay for OP, it should be noted that some quan-
titative agreement between the methods has been reported with
the DTT method and the OPGSH metric being largely comparable,
being based on thiol oxidation (Janssen et al., 2015; Künzli et al.,
2006).
Our observation of positive associations between ascorbate
dependent OP and cardiovascular and respiratory hospital admis-
sions in the populations less than 65 during the warmer periods
of the year is consistent with an emerging literature suggesting
seasonal difference in the toxicity of ambient PM (Hamad et al.,
2016), including evidence of increased oxidative activity/toxicity
associated with photochemical aging (Kunzi et al., 2015; Saffari
et al., 2014). Whilst this association should be interpreted with cau-
tion, as it represented a secondary analysis, we  believe it warrants
further investigation.
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. Conclusions
We  found little evidence for short-term associations between
article OP and mortality and hospital admissions in London. To
ate, evidence from the small number of experimental and epi-
emiological studies does not support the hypothesis that particles,
hatever their source, act on the human body via common mech-
nisms related to the capacity of the particles to cause damaging
xidation reactions or oxidative stress. However, the evidence base
s very limited and further studies with improved exposure assess-
ent and greater statistical power are required to conﬁrm or reject
he role of particle OP in triggering exacerbations of disease.
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